MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
6.93
+0.71 (11.41%)
At close: Nov 6, 2026, 4:00 PM EST
7.10
+0.17 (2.45%)
After-hours: Nov 6, 2026, 7:52 PM EST
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $385.14 million as of November 6, 2026. It is the 16,087th most valuable company in the world and the 2,913th biggest in the United States. Its market cap has decreased by 44.84% in one year.
Market Cap
385.14M
Enterprise Value
82.40M
1-Year Change
-44.84%
Global Rank
Country Rank
#2,913 United States
Category
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has decreased from $704.29M to $385.14M, a decrease of -45.32%. That is a compound annual growth rate of -44.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 385.14M | -49.76% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 358.33M |
| Avalo Therapeutics | 355.57M |
| TRex Bio | 349.72M |
| Contineum Therapeutics | 345.93M |
| AgomAb Therapeutics NV | 343.26M |
| Atea Pharmaceuticals | 338.46M |
| Orchestra BioMed Holdings | 337.79M |
| Autolus Therapeutics | 335.36M |